This inventor holds 2 USPTO granted patents and 1 published patent application and 10 EPO patents. Top assignee: Conopco, Inc.. Active years: 2025.
Company Filing History:
Years Active: 2025
Title: Mark Lawrence Thompson: Innovator in Rhamnolipid Production
Introduction
Mark Lawrence Thompson is an accomplished inventor based in Ellesmere Port, GB. He has made significant contributions to the field of biochemistry, particularly in the production of rhamnolipids. With a total of 2 patents to his name, Thompson's work has the potential to impact various industries, including pharmaceuticals and biotechnology.
Latest Patents
Thompson's latest patents focus on innovative processes to produce mono-rhamnolipids. The first patent describes a method to convert di-rhamnolipid to mono-rhamnolipid using an α-L-rhamnosidase enzyme with a sequence identity of at least 70% with either SEQ ID. 1 or SEQ. ID 2. The second patent outlines a detailed process that involves contacting a starting di-rhamnolipid material with an immobilized α-L-rhamnosidase enzyme, followed by the separation of the produced mono-rhamnolipid from the reaction medium and/or side products. Notably, the α-L-rhamnosidase enzyme used in this process does not exhibit β-D-glucosidase activity.
Career Highlights
Throughout his career, Mark Lawrence Thompson has worked with notable companies such as Conopco, Inc. and Unilever IP Holdings B.V. His experience in these organizations has allowed him to refine his expertise in the field of biochemistry and innovation.
Collaborations
Thompson has collaborated with talented individuals, including Natalia Eliza Iyke Domeradzka and Dietmar Andreas Lang. These partnerships have contributed to the advancement of his research and the successful development of his patents.
Conclusion
Mark Lawrence Thompson is a notable inventor whose work in the production of mono-rhamnolipids showcases his innovative spirit and dedication to advancing biochemistry. His contributions are likely to have a lasting impact on the industry.